| | | | | | | | | Sponsored | | Your broken LIS is draining resources and bottlenecking your daily lab output. Period. So, how about stopping the bleeding revenue due to inefficient workflows? Get the free report and unlock actionable insights and practical checklists to upgrade your operations, slash turnaround times, and crush industry demands. Don’t let your competition outpace you while you rely on legacy tech. |
|
|
| | |
| |
| | |
|
|
| | | | | | Medical Laboratory Observer is offering two free continuing education webinars in May, covering stroke care and STI diagnostics. Each live webinar is worth one CE credit. |
|
|
| | For Skin Cancer Awareness Month, the American Academy of Dermatology (AAD) has published new data regarding its Practice Safe Sun Survey. Alongside the results, the organization warns that misinformation is impacting skin cancer risk. |
|
|
| | On Tuesday, May 5, our May 2026 issue will be published. Articles will include a CE on informatics and AI, the results of our lab management survey, and more! |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | We understand what’s at stake–timely detection of transplant-associated viral targets can be critical. Our transplant-focused ASR§ portfolio is designed to support the needs of mid-volume molecular labs to develop their own LDTs without compromising flexibility or workflow efficiency. See our full menu of ASRs§ available for BK virus, CMV, EBV, HHV-6, 7 & 8, JCV, and VZV. |
|
|
| | |
| |
| | |
|
|
| | | | | | This online exclusive article analyzes contemporary competencies required for MLT students, highlighting the importance of standardized essential functions to ensure safety, quality, and consistency in clinical laboratory education and practice. |
|
|
|
| |
| | |
|
|
| | | | | | NeoGenomics, Inc. announced that its oncology testing portfolio is now available through Epic Aura, enabling seamless access to oncologists and health systems across the United States through the Epic electronic health record (EHR) workflow. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
